Beijing Hotgen Biotech Co., Ltd. (abbreviated as Hotgen Biotech, stock code: 688068) was established in June
2005, which is a high-tech enterprise focusing on the research& development, manufacture and sales of medical and
public safety inspection products of in vitro diagnostics (IVD) in the field of biomedicine, as well as landed on the
China Sci-Tech innovation board (STAR Market) in September 2019.
After serval years of Research& development, Hotgen Biotech has developed an in vitro diagnostic reagent
bioactive raw material development platform, a sugar chain abnormal protein detection (sugar capture) R&D
technology platform, a Magnetic particles chemiluminescence R&D technology platform, a Up-converting Phosphor
R&D technology platform, and a colloidal gold immune layer, The eight major technology platforms, such as the
precipitation R&D platform, enzyme-linked immunoassay R&D technology platform, molecular diagnostics R&D
platform, and instrument R&D technology platform, form a closed-loop system for in vitro diagnostic R&D and
production. Hotgen Biotech has established a complete full level immunodiagnostic technology platform, from
high-precision Up-converting Phosphor POCT (UPT series) to small, medium and large single- cartridge
chemiluminescence platforms (MQ60 series), and then to large-scale full-automatic chemiluminescence Platform
(C2000), which realizes the application of the immune diagnostic platform in the field of full diagnostic scenarios.
Supporting products are widely used in the clinical and public safety fields. Specific users include hospitals at all
levels, township health centers, third-party testing centers, and medical institutions, as well as medical and health
institutions, as well as disease control centers, public security, fire protection, military, ports, food and medicine.
Supervision, food and feed enterprises and other public safety fields.
Hotgen Biotech has won the second prize of the National Technology Invention Award, the Gold Medal of
Independent Innovation, and the second prize of the Chinese Medical Science and Technology Award; In 2018,
Hotgen Biotech was awarded the second prize of the “Technical Invention Category of China Rare Earth Science and
Technology Award” by the China Rare Earth Society; Top 100 Private Scientific and Technological Innovations
“and” Top 100 Medical Enterprises of the Future “; and” Postdoctoral Scientific Research Workstation “; major
science and technology projects in the 12th and 13th five years, 863 plan, science and technology projects of the
Beijing Science and Technology Commission, and Zhongguancun High Precision The project’s major cutting-edge
original technological achievements transformation and industrialization projects.
In the face of the COVID-19 epidemic situation, Beijing Hotgen Biotech Co.,Ltd has organized R&D
developed a variety of Covid-19 detection reagents, including Novel Coronavirus 2019-nCoV Antigen Test
(Colloidal Gold), Novel Coronavirus 2019-nCoV Antigen Test (Up-converting Phosphor Immunochromatographic
Technology), Coronavirus disease(COVID-19) Antibody Test (Colloidal Gold), Coronavirus disease(COVID-19)
IgM/IgG Antibody Rapid Test(Colloidal Gold), Novel Coronavirus 2019-nCoV Antibody Test (Up-converting
Phosphor Immunochromatographic Technology), Novel Coronavirus (SARS-CoV-2) Neutralizing Antibodies Test
(Colloidal Gold), Coronavirus disease( COVID-19) Nucleic Acid Test Kit (PCR-Fluorescent Probe Method),
Disposable virus sampling tube, Nucleic acid Automatic Purification System, Nucleic acid extraction reagent,
Biological Sample Releaser kit, etc.It is imperative to fight the epidemic Helping the global fight against epidemics!
Since its establishment, the company has continuously grown its business and has now achieved group
development. At present, Hotgen (Langfang), Hotgen (Jilin), Weikekang Technology, Shunjing Biological and many
other subsidiaries have been established. Hotgen Biotech marketing and service network has covered all regions of
the country. Each province is equipped with professional technical service engineers, academic engineers, etc. who
are responsible for pre-sales and after-sales work to meet customer needs. The company takes “developing
biotechnology and benefiting human health” as its mission, “quality determines the company’s life and death,
customers determine the company’s success or failure, talents determine the company’s rise and fall, innovation
determines the company’s future” as its core values, and “tests because of me advanced” as its philosophy , High
ambitions, technological entrepreneurship, and industrial prosperity!
HOTGEN Coronavirus (2019-nCoV)-Antigentest EC zertifiziert einzeln verpackt
636,00 €
0,00 € / Stück
exkl. MwSt. zzgl. Versandkosten
Beijing Hotgen Biotech Co., Ltd. (abbreviated as Hotgen Biotech, stock code: 688068) was established in June 2005, which is a high-tech enterprise focusing on the research& development, manufactu
Menge | 400 Stück |
---|
There are no reviews yet.